Madopar Hbs

Benserazide and Levodopa, the active ingredient in Madopar Hbs, is a Levodopa/benserazide combination presented as an oral tablet formulation for oral use. It is indicated for the management of Parkinson's disease and related Parkinsonian syndromes in adult patients. GNH USA supplies Madopar Hbs as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Madopar Hbs is a Levodopa/benserazide combination used in the dopaminergic pathway to treat movement disorders. - Parkinson's disease: improves motor control and reduces rigidity, tremor, and bradykinesia. - Parkinsonian syndrome: alleviates symptoms caused by dopamine deficiency after drug‑induced or vascular injury. - Secondary Parkinsonism: helps control motor signs when Parkinson‑like features arise from other neurological conditions.

Adverse reactions may vary in frequency and severity.

Common Side Effects: - Nausea: mild to moderate gastrointestinal upset. - Dizziness: sensation of light‑headedness, especially on standing. - Orthostatic hypotension: drop in blood pressure upon standing. - Headache: transient cranial discomfort. - Insomnia: difficulty initiating or maintaining sleep. - Dry mouth: reduced salivation.

Serious or Rare Side Effects: - Dyskinesia: involuntary, erratic movements. - Hallucinations: visual or auditory perceptual disturbances. - Severe hypotension: marked blood pressure fall requiring medical attention. - Neuroleptic malignant syndrome: life‑threatening reaction with fever and rigidity. - Cardiac arrhythmias: irregular heart rhythms. - Anaphylaxis: acute allergic reaction with airway compromise.

When prescribing Madopar Hbs, clinicians should consider several safety measures. - Monitor blood pressure: watch for orthostatic changes, especially in the elderly. - Assess psychiatric status: be alert for hallucinations or confusion. - Adjust dose in renal impairment: consider lower doses or extended intervals. - Avoid abrupt discontinuation: taper gradually to prevent withdrawal symptoms. - Store at room temperature: keep in the original pack, protect from moisture and direct sunlight.

Madopar Hbs may interact with other medicines, requiring careful management.

Major Interactions (Avoid): - Non‑selective MAO inhibitors (e.g., phenelzine): risk of hypertensive crisis. - Typical antipsychotics (e.g., haloperidol): may block dopaminergic effect. - High‑dose pyridoxine (vitamin B6): accelerates peripheral levodopa metabolism.

Moderate Interactions (Monitor Closely): - COMT inhibitors (e.g., entacapone): may increase levodopa plasma levels. - MAO‑B inhibitors (e.g., selegiline): additive dopaminergic effect. - Antihypertensive agents: potential for exaggerated blood‑pressure lowering.